IGC Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Cap	26	23	27	18	48	86
Market Cap Growth	6.57%	-13.59%	48.04%	-62.80%	-43.41%	344.34%
Enterprise Value	25.34	22.79	25.7	15.02	38.47	71.97
Last Close Price	0.26	0.28	0.40	0.34	0.95	1.79
Forward PE	-	4.35	4.35	4.35	4.35	4.35
PEG Ratio	-	2.26	2.26	2.26	2.26	2.26
PS Ratio	23.80	18.14	19.83	19.78	122.03	95.34
PB Ratio	2.99	3.64	3.64	1.21	2.03	2.61
EV/Sales Ratio	22.91	17.93	19.11	16.49	96.90	80.14
Debt / Equity Ratio	0.02	0.02	0.03	0.02	0.02	0.03
Net Debt / Equity Ratio	-0.10	-0.04	-0.13	-0.20	-0.42	-0.42
Net Debt / EBITDA Ratio	0.13	0.04	0.11	0.28	0.68	1.65
Net Debt / FCF Ratio	0.18	0.05	0.18	0.41	1.30	1.11
Asset Turnover	0.12	0.14	0.10	0.04	0.01	0.03
Inventory Turnover	0.54	0.45	0.29	0.15	0.04	0.16
Quick Ratio	0.77	0.18	0.53	1.82	4.34	6.25
Current Ratio	1.32	1.28	1.58	3.41	6.19	9.93
Return on Equity (ROE)	-89.83%	-104.33%	-116.95%	-59.30%	-52.97%	-29.70%
Return on Assets (ROA)	-86.01%	-79.85%	-72.36%	-52.58%	-49.21%	-26.90%
Return on Invested Capital (ROIC)	-124.05%	-119.62%	-107.12%	-89.48%	-93.20%	-51.43%
Return on Capital Employed (ROCE)	-110.50%	-105.98%	-85.79%	-58.33%	-53.30%	-28.82%
Buyback Yield / Dilution	-19.49%	-30.04%	-11.91%	-5.17%	-19.13%	-6.26%
Total Shareholder Return	-19.49%	-30.04%	-11.91%	-5.17%	-19.13%	-6.26%

SEC Filings: 10-K · 10-Q